Arginase l (human) (recombinant) |
 |
| PRODUCT LINE | Nitric Oxide Pathway |
|
|
| PRODUCT FAMILIES | Arginine & Arginases / Related Products |
|
|
|
| Ordering Information |
|
| Product Numbers | Format | Size | Unit Price | Quantity | | | ALX-201-081-C020 |
|
20 µg | | | | | | |
|
|
| Product Specification |
|
|
| EC: | 3.5.3.1 |
|
|
| |
|
| SOURCE/HOST: | Produced in E. coli. Full length human arginase I. |
|
|
| |
|
| CONCENTRATION: | |
|
|
| |
|
| PURITY: | ≥90% (SDS-PAGE) |
|
|
| |
|
| FORMULATION: | Liquid. In 10mM TRIS-HCl, pH 7.5, containing 1mM β-mercaptoethanol, 1mM MnCl2 and 50% glycerol. |
|
|
| |
|
| SPECIFIC ACTIVITY: | ~2.0U/µg protein. One unit is defined as the amount of enzyme that converts 1µmol of L-arginine to L-ornithine and urea per min. at 37°C, pH 9.5 (R.T. Schminke, et al.; J. Biol. Chem. 238, 1012 (1962)). |
|
|
| |
|
| SHIPPING: | SHIPPED ON DRY ICE |
|
|
| |
|
| LONG TERM STORAGE: | -80°C |
|
|
|
| | Product Specific Literature References | Determination of arginase activity in macrophages: a micromethod: I.M. Corraliza, et al.; J. Immunol. Methods 174, 231 (1994) Abstract
Implications of the S-shaped domain in the quaternary structure of human arginase: A. Mora, et al.; Biochim. Biophys. Acta 1476, 181 (2000) Abstract |
|
| | General Information | |
Background/Technical Information | | Swiss-Prot link P05089: Arginase I (human) | | |
|
|
|
| RELATED PRODUCT GROUPS |
Enzymes / Proteins > Recombinant Proteins / Fusion Proteins |
|
|
|
